Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Mar 17;70(7):1438-1441.
doi: 10.1093/cid/ciz370.

To Bridge, Blossom, or Boost: That Is the Question

Sandra M Arend  1 , Inge Jedema  2
Affiliations
Comment

To Bridge, Blossom, or Boost: That Is the Question

Sandra M Arend et al. Clin Infect Dis. .
No abstract available

Keywords: adoptive T cell therapy; cytomegalovirus; stem cell transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Simplified conceptual model of the possible contributions of adoptive cytomegalovirus (CMV)–specific T-cell therapy to posttransplantation anti-CMV immunity. All cell types mentioned in the graphs represent CMV-specific T cells. Abbreviations: ATC, adoptive T-cell therapy with cytomegalovirus-specific T cells; ATG, antithymocyte globulin; CMI, cell-mediated immunity; CMV, cytomegalovirus; HSCTx, hematopoietic stem cell transplantation.
See this image and copyright information in PMC

Comment on

References

    1. Balfour HH., Jr Cytomegalovirus: the troll of transplantation. Arch Intern Med 1979; 139:279–80. - PubMed
    1. Leen AM, Heslop HE, Brenner MK. Antiviral T-cell therapy. Immunol Rev 2014; 258:12–29. - PMC - PubMed
    1. Maffini E, Giaccone L, Festuccia M, Brunello L, Busca A, Bruno B. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol 2016; 9:585–96. - PubMed
    1. Pande A, Dubberke ER. Cytomegalovirus infections of the stem cell transplant recipient and hematologic malignancy patient. Infect Dis Clin North Am 2019; 33:485–500. - PubMed
    1. van der Heiden P, Marijt E, Falkenburg F, Jedema I. Control of cytomegalovirus viremia after allogeneic stem cell transplantation: a review on CMV-specific T cell reconstitution. Biol Blood Marrow Transplant 2018; 24:1776–82. - PubMed

Substances